Immunodrug Qa-Derp1: Phase I

Updated interim results from an open-label, Swiss Phase I study showed that 12 volunteers receiving a 50 ?g subcutaneous or intramuscular Qa-Derp1 injection had antibody responses with ELISA titers be...